Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,446 | 20,994 | 13,901 | 16,762 | 20,715 |
| Receivables | 4,734 | 6,573 | 7,538 | 5,289 | 7,197 |
| Inventories | 6,326 | 5,621 | 3,623 | 3,201 | 2,584 |
| Other current assets | 0 | 0 | 0 | 0 | 900 |
| TOTAL | $35,973 | $34,727 | $25,934 | $26,386 | $32,227 |
| Non-Current Assets | |||||
| PPE Net | 15,229 | 13,366 | 12,850 | 13,041 | 13,226 |
| Intangibles | 9,867 | 9,311 | 11,608 | 12,685 | 2,828 |
| Other Non-Current Assets | 151 | 167 | 185 | 96 | 11,811 |
| TOTAL | $25,247 | $22,844 | $24,643 | $25,822 | $27,865 |
| Total Assets | $61,220 | $57,571 | $50,577 | $52,208 | $60,092 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,038 | 3,893 | 2,004 | 2,873 | 2,805 |
| Accrued Expenses | 5,615 | 5,271 | 3,430 | 1,901 | 2,488 |
| TOTAL | $16,340 | $14,992 | $9,839 | $9,491 | $6,297 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,253 | 2,203 | 2,897 | 3,289 | 3,745 |
| Deferred Revenues | 6,141 | 5,624 | 4,167 | 4,474 | 754 |
| Other Non-Current Liabilities | 115 | 56 | 0 | 0 | 379 |
| TOTAL | $3,368 | $2,259 | $3,676 | $4,842 | $6,367 |
| Total Liabilities | $19,708 | $17,251 | $13,515 | $14,333 | $12,664 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,975 | 10,844 | 10,802 | 10,775 | 12,155 |
| Common Shares | 123 | 123 | 122 | 122 | 122 |
| Retained earnings | -238,961 | -237,360 | -243,311 | -241,815 | -241,662 |
| Other shareholders' equity | -2,758 | -4,079 | -213 | 908 | 1,920 |
| TOTAL | $41,512 | $40,320 | $37,062 | $37,875 | $47,428 |
| Total Liabilities And Equity | $61,220 | $57,571 | $50,577 | $52,208 | $60,092 |